Mitsui & Co., Ltd. (MITSY)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	59,048	53,719	70,344	45,949	43,874	34,809
Market Cap Growth	-23.63%	-23.63%	53.09%	4.73%	26.04%	45.90%
Enterprise Value	86,424	82,161	96,763	76,643	78,820	71,473
Last Close Price	411.24	379.85	468.99	305.49	258.15	193.53
PE Ratio	9.82	8.94	10.00	5.40	5.82	11.48
PS Ratio	0.60	0.55	0.80	0.43	0.45	0.48
PB Ratio	1.14	1.04	1.37	0.93	0.92	0.80
P/TBV Ratio	1.26	1.14	1.50	1.00	1.00	0.88
P/FCF Ratio	13.17	11.98	18.68	7.45	8.57	6.91
P/OCF Ratio	8.69	7.91	12.31	5.83	6.60	4.98
EV/Sales Ratio	0.88	0.84	1.10	0.71	0.81	0.99
EV/EBITDA Ratio	10.46	18.51	18.19	11.16	11.95	19.23
EV/EBIT Ratio	13.96	28.74	26.54	14.51	17.57	46.52
EV/FCF Ratio	19.28	18.33	25.69	12.43	15.40	14.19
Debt / Equity Ratio	0.62	0.62	0.62	0.77	0.84	0.98
Debt / EBITDA Ratio	6.57	6.57	5.53	5.22	5.75	10.38
Debt / FCF Ratio	7.21	7.21	8.38	6.15	7.85	8.52
Asset Turnover	0.87	0.87	0.83	0.94	0.86	0.66
Inventory Turnover	13.89	13.89	12.60	13.66	13.57	12.32
Quick Ratio	0.90	0.90	0.85	0.95	0.91	1.05
Current Ratio	1.56	1.56	1.48	1.51	1.50	1.56
Return on Equity (ROE)	11.87%	11.87%	15.07%	18.68%	17.66%	7.89%
Return on Assets (ROA)	1.59%	1.59%	2.14%	2.90%	2.48%	0.87%
Return on Capital (ROIC)	2.13%	2.13%	2.85%	3.94%	3.36%	1.15%
Return on Capital Employed (ROCE)	3.30%	3.30%	4.20%	6.00%	4.90%	1.70%
Earnings Yield	10.18%	11.19%	10.00%	18.51%	17.17%	8.71%
FCF Yield	7.59%	8.35%	5.35%	13.42%	11.66%	14.47%
Dividend Yield	0.17%	0.18%	0.12%	0.17%	0.17%	0.20%
Payout Ratio	30.45%	30.45%	22.79%	17.52%	16.20%	40.38%
Buyback Yield / Dilution	2.63%	2.63%	3.75%	3.82%	3.25%	2.79%
Total Shareholder Return	2.80%	2.81%	3.87%	3.99%	3.42%	2.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.